🏛️ Verified NIH Record • Updated 2026-05-27
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE (NCT06777368)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Medtronic Cardiovascular
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years to 105 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (71 Sites)
Showing the first 25 of 71 sites.
- University of Alabama at Birmingham — Birmingham, Alabama
- Abrazo Arizona Heart Hospital — Phoenix, Arizona
- Tucson Medical Center — Tucson, Arizona
- Kaiser Permanente Los Angeles Medical Center — Los Angeles, California
- Sutter Heatlh — Sacramento, California
- Kaiser Permanente Northern California — Sacramento, California
- Stanford Hospital & Clinics — Stanford, California
- Los Robles Regional Medical Center — Thousand Oaks, California
- Medical Center of the Rockies — Loveland, Colorado
- Hartford Hospital — Hartford, Connecticut
- Yale New Haven Hospital — New Haven, Connecticut
- MedStar Washington Medical Center — Washington D.C., District of Columbia
- Morton Plant Hospital — Clearwater, Florida
- HealthPark Medical Center, Lee Memorial Health — Fort Myers, Florida
- Orlando Health/Orlando Regional Medical Center — Orlando, Florida
- Tampa General/USF — Tampa, Florida
- Parkview Health — Fort Wayne, Indiana
- Saint Vincent Heart Center of Indiana — Indianapolis, Indiana
- MercyOne Iowa Heart Center — Des Moines, Iowa
- University of Iowa Hospitals and Clinics — Iowa City, Iowa
- The University of Kansas — Kansas City, Kansas
- Ascension Via Christi St. Francis — Wichita, Kansas
- Maine Medical Center — Portland, Maine
- Medstar Union Memorial Hospital — Baltimore, Maryland
- The Johns Hopkins Hospital — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (763) 514-4000
Email: RS.RESTORESTUDY@medtronic.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aortic Stenosis
- PERIGON Pivotal Trial — Los Angeles, California
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement — Birmingham, Alabama
- PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis — Birmingham, Alabama
- Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study — Tucson, Arizona
- Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study) — Edmonton, Alberta
- Systematic Ambulatory ECG Monitoring Following TAVI — Québec, Quebec
Explore by condition: All Aortic Stenosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.